Clinical Trial Update: PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) [Phase 2, Phase 3]

View source ↗

Summary

A COVID-19 related preventive study (PREVENT) in Phase 2/3 was withdrawn from clinical trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Respiratory Infection
• Respiratory Tract Diseases
• Respiratory Viral Infection

Snippet

Sponsor: Thirty Respiratory Limited | Conditions: Respiratory Viral Infection, Respiratory Tract Diseases | Phase 2, Phase 3 | Status: WITHDRAWN